Erratum: Fetal cardiac function between 11 and 35 weeks gestation and nuchal translucency thickness (Ultrasound Obstet Gynecol (2011) 37 (48-56) DOI: 10.1002/uog.8807);Fetal cardiac function between 11 and 35 weeks' gestation and nuchal translucency thickness

Ultrasound in Obstetrics and Gynecology

Volumn 37, Issue 1, 2011, Pages 48-56

  Clur, S A B ^a,b   Oude Rengerink, K ^c   Mol, B W J ^c   Ottenkamp, J ^a,b   Bilardo, C M ^c,d  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b Centre for Congenital Heart Anomalies Amsterdam Leiden   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

cardiac function; Doppler; ductus venosus; fetus; nuchal translucency

Indexed keywords

ARTICLE; BLOOD FLOW VELOCITY; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; FETUS HEART; FETUS MONITORING; GESTATIONAL AGE; HUMAN; MALE; METHODOLOGY; NUCHAL TRANSLUCENCY MEASUREMENT; PHYSIOLOGY; PREGNANCY; PROSPECTIVE STUDY; REPRODUCIBILITY;

BLOOD FLOW VELOCITY; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FETAL HEART; FETAL MONITORING; GESTATIONAL AGE; HUMANS; MALE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 78649666490     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.10090     Document Type: Erratum

References (49)

1. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K,. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992; 304: 867-869.
2. Pajkrt E, Bilardo CM, van Lith JMM, Mol BWJ, Bleker OP,. Nuchal translucency measurement in normal fetuses. Obstet Gynecol 1995; 86: 994-997.
3. Hyett J, Moscoso G, Papapanagiotou G, Perdu M, Nicolaides KH,. Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 1996; 4: 245-250.
4. Hyett JA, Perdu M, Sharland GK, Snijders RS, Nicolaides KH,. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects. Ultrasound Obstet Gynecol 1997; 10: 242-246.
5. Souka AP, Snijders RJ, Novakov A, Soares W, Nicolaides KH,. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 1998; 11: 391-400.
6. Souka AP, Von Kaisenberg CS, Hyett JA, Sonek JD, Nicolaides KH,. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol 2005; 192: 1005-1021.
7. Bilardo CM, Pajkrt E, de Graaf I, Mol BW, Bleker OP,. Outcome of fetuses with enlarged nuchal translucency and normal karyotype. Ultrasound Obstet Gynecol 1998; 11: 401-406. (Pubitemid 28344741)
8. Bilardo CM, Müller MA, Zikulnig L, Schipper M, Hecher K,. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome. Ultrasound Obstet Gynecol 2001; 17: 288-294.
9. Bilardo CM, Müller MA, Pajkrt E, Clur SA, van Zalen MM, Bijlsma EK,. Increased nuchal translucency and normal karyotype: time for prenatal reassurance. Ultrasound Obstet Gynecol 2007; 30: 11-18.
10. Makrydimas G, Sotiriadis A, Ioannidis JP,. Screening performance of first-trimester nuchal translucency for major cardiac defects: A meta-analysis. Am J Obstet Gynecol 2003; 189: 1330-1335.
11. Makrydimas G, Sotiriadis A, Huggon IC, Simpson J, Sharland G, Carvalho JS, Daubeney PE, Ioannidis JP,. Nuchal transclucency and fetal cardiac defects: A pooled analysis of major fetal echocardiography centers. Am J Obstet Gynecol 2005; 192: 89-95.
12. Montenegro N, Matias A, Areias JC, Castedo S, Barros H,. Increased fetal nuchal translucency: possible involvement of early cardiac failure. Ultrasound Obstet Gynecol 1997; 10: 265-268.
13. Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH,. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks. Ultrasound Obstet Gynecol 1999; 14: 307-310.
14. Hyett J, Moscoso G, Nicolaides K,. Increased nuchal translucency in trisomy 21 fetuses: relationship to narrowing of the aortic isthmus. Hum Reprod 1995; 10: 30-36.
15. Simpson JM, Sharland G,. Nuchal translucency and congenital heart defects: heart failure or not? Ultrasound Obstet Gynecol 2000; 16: 30-36.
16. Rizzo G, Muscatello A, Angelini E, Capponi A,. Abnormal cardiac function in fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 2003; 21: 539-542.
17. Hata T, Inubashiri E, Kanenishi K, Akiyama M, Tanaka H, Shiota A, Yanagihara T, Ohno M,. Nuchal translucency thickness and fetal cardiac flow velocity in normal fetuses at 11-13 weeks of gestation. Gynecol Obstet Invest 2002; 53: 209-213.
18. Huggon IC, Turan O, Allan LD,. Doppler assessment of cardiac function at 11-14 weeks' gestation in fetuses with normal and increased nuchal translucency. Ultrasound Obstet Gynecol 2004; 24: 390-398.
19. Haak MC, Twisk JW, Bartelings MM, Gittenberger-de Groot AC, van Vugt JM,. First-trimester fetuses with increased nuchal translucency do not show altered intracardiac flow velocities. Ultrasound Obstet Gynecol 2005; 25: 246-252.
20. Lee W, Allan L, Carvalho JS, Chaoui R, Copel J, DeVore G, Hecher K, Munoz H, Nelson T, Paladini D, Yagel S,. ISUOG consensus statement: what constitutes a fetal echocardiogram? Ultrasound Obstet Gynecol 2008; 32: 239-242.
21. Simpson JM, Cook A,. Repeatability of echocardiographic measurements in the human fetus. Ultrasound Obstet Gynecol 2002; 20: 332-339.
22. Raboisson MJ, Bourdages M, Fouron JC,. Measuring left ventricular myocardial performance in fetuses. Am J Cardiol 2003; 91: 919-921.
23. Hernandez-Andrade E, Lopez-Tenorio J, Figueroa-Diesel H, Sanin-Blair J, Carreras E, Cabero L, Gratacos E,. A modified myocardial performance (Tei) index based on the use of valve clicks improves reproducibility of fetal left cardiac function measurement. Ultrasound Obstet Gynecol 2005; 26: 227-232.
24. Geva T,. Echocardiography and Doppler ultrasound. In The Science and Practice of Pediatric Cardiology., Garson A, Bricker JT, Fisher DJ, (eds). Williams and Wilkins: Baltimore, MD, 1998; 834-844.
25. Pacileo G, Paladini D, Pisacane C, Palmieri S, Russo MG, Calabrio R,. Role of changing loading condition on atrioventricular flow velocity patterns in normal human fetuses. Am J Cardiol 1994; 73: 991-993.
26. Tei C, Ling L, Hodge D, Bailey K, Ok J, Rodenheffer R, Tajik A, Steward J,. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac functionâa study in normal and dilated cardiomyopathy. J Cardiol 1995; 26: 357-366.
27. St John Sutton M, Gill T, Plappert T, Saltzman DH, Doubilet P,. Assessment of right and left ventricular function in terms of force development with gestational age in the normal fetus. Br Heart J 1991; 66: 285-289.
28. Teixeira LS, Leite J, Viegas MJ, Faria MM, Chaves AS, Teixeira RC, Pires MC, Pettersen H,. Ductus venosus Doppler velocimetry in the first trimester: a new finding. Ultrasound Obstet Gynecol 2008; 31: 261-265.
29. Twisk JWR,. Applied Multilevel Analysis, a Practical Guide. Cambridge University Press: Cambridge, UK, 2007.
30. Tulzer G, Khowasathit P, Gudmundsson S, Wood DC, Tian ZY, Schmitt K, Huhta JC,. Diastolic function of the fetal heart during second and third trimester: a prospective longitudinal Doppler-echocardiographic study. Eur J Pediatr 1994; 153: 151-154.
31. Leiva MC, Tolosa JE, Binotto CN, Wiener S, Huppert L, Denis AL, Huhta JC,. Fetal cardiac development and haemodynamics in the first trimester. Ultrasound Obstet Gynecol 1999; 14: 167-174.
32. Van Splunder P, Stijnen T, Wladimiroff J,. Fetal atrioventricular flow-velocity waveforms at 8 to 20 weeks of gestation. Circulation 1996; 94: 1372-1373.
33. Zhang H, Otsuji Y, Matsukida K, Hamasaki S, Yoshifuku S, Kumanohoso T, Koriyama C, Kisanuki A, Minagoe S, Tei C,. Noninvasive differentiation of normal from pseudonormal/restrictive mitral flow using Tei index combining systolic and diastolic function. Circ J 2002; 66: 831-836.
34. Gardin JG,. Doppler measurements of aortic blood flow velocity and acceleration: load independent indexes of left ventricular performance? Am J Cardiol 1989; 64: 935-936.
35. St John Sutton M, Wiegers SE,. The Tei Indexâa role in the diagnosis of heart failure? Eur Heart J 2000; 21: 1822-1824.
36. Miki S, Murakami T, Iwase T, Tomita T, Nakamwa Y, Kawai C,. Doppler echocardiographic transmitral peak early velocity does not directly reflect hemodynamic changes in humans: importance of normalization to mitral stroke volume. J Am Coll Cardiol 1991; 17: 1507-1516.
37. Zoppi MA, Ibba RM, Putzolu M, Floris M, Monni G,. First trimester umbilical artery pulsatility index in fetuses presenting with an enlarged nuchal translucency. Prenat Diagn 2000; 20: 701-704.
38. Mercé LT, Barco MJ, Alcázar JL, Sabatel R, Troyano J,. Intervillous and uteroplacental circulation in normal early pregnancy and early pregnancy loss assessed by 3-dimensional power Doppler angiography. Am J Obstet Gynecol 2009; 200: 315.e1-8.
39. Mäkikallio K, Jouppila P, Räsänen J,. Human fetal cardiac function in the first trimester of pregnancy. Heart 2005; 91: 334-338.
40. Ninno MAP, Liao AW, Lamberty CO, Miguelez J, Zugaib M,. Fetal tricuspid valve Doppler at 11-13 weeks and 6 days: reference values and reproducibility. Prenat Diagn 2010; 30: 790-794.
41. Huggon IC, DeFigueiredo DB, Allan LD,. Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11-14 weeks of gestation. Heart 2003; 89: 1071-1073.
42. Vinkestijn AS, Ursem NT, Struijk PC, Wladimiroff JW,. Fetal heart rate and blood flow velocity variability in the presence of increased nuchal translucencyâa preliminary study. Ultrasound Obstet Gynecol 2004; 23: 19-22.
43. Martinez JM, Echevarría M, Gõmez O, Del Río M, Borrell A, Puerto B, Fortuny A,. Jugular vein and carotid artery blood flow in fetuses with increased nuchal translucency at 10-14 weeks' gestation. Ultrasound Obstet Gynecol 2003; 22: 464-469. (Pubitemid 37500692)
44. Bahtiyar MO, Copel J,. Cardiac changes in the intrauterine growth-restricted fetus. Semin Perinatol 2008; 32: 190-193.
45. Kiserud T, Kessler J, Ebbing C, Rasmussen S,. Ductus venosus shunting in growth-restricted fetuses and the effect of umbilical circulatory compromise. Ultrasound Obstet Gynecol 2006; 28: 143-149.
46. Bellotti M, Pennati G, Pardi G, Fumero R,. Dilatation of the ductus venosus in human fetuses: ultrasonographic evidence and mathematical modeling. Am J Physiol Heart Circ Physiol 1998; 275: 1759-1767.
47. Bellotti M, Pennati G, De Gasperi C, Bozz M, Battaglia FC, Ferrazzi E,. Simultaneous measurements of umbilical venous, fetal hepatic, and ductus venosus blood flow in growth-restricted human fetuses. Am J Obstet Gynecol 2004; 190: 1347-1358.
48. Allan LD,. The mystery of the nuchal translucency. The Mannheimer Lecture. Cardiol Young 2006; 16: 11-17.
49. Kelekci S, Yilmaz B, Savan K, Sonmez S,. Can increased nuchal translucency in the first trimester of pregnancy predict gestational diabetes mellitus. J Obstet Gynecol 2005; 25: 579-582.